Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5602-5613
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5602
Table 3 Primary and secondary outcomes
Outcomes
Total
Time to ERCP divided by 24 h
Time to ERCP divided by 48 h
ERCP ≤ 24 h
ERCP > 24 h
P value
ERCP ≤ 48 h
ERCP > 48 h
P value
Overall n = 683n = 134n = 549n = 314n = 369
30-d mortality, n (%)7 (1.02)07 (1.3)0.35607 (1.9)0.017
ICU admission, n (%)37 (5.4)15 (11.2)22 (4)0.00122 (7.0)15 (4.07)0.091
LOHS in d17 (5-10)6 (4-10)7 (5-10)0.0186 (4-9)8 (6-11)< 0.001
30-d readmission, n (%)87 (12.7)16 (11.9)71 (12.9)0.75740 (12.7)47 (12.7)0.999
Grade III ACn = 170n = 39n = 131n = 72n = 98
30-d mortality, n (%)6 (3.5)06 (4.6)0.33806 (6.1)0.039
ICU admission, n (%)26 (15.3)12 (9.0)14 (2.6)0.00216 (22.2)10 (10.2)0.031
LOHS in d17 (7-14)10 (6-16.5)9 (7-12)0.6379 (6-15)9 (7-12)0.448
30-d readmission, n (%)23 (13.5)4 (3)19 (14.5)0.60210 (13.9)13 (13.3)0.906
Grade II ACn = 179n = 39n = 140n = 88n = 91
30-d mortality, n (%)000-00-
ICU admission, n (%)5 (2.8)2 (5.1)3 (2.1)0.2993 (3.4)2 (2.2)0.679
LOHS in d17 (5-10)6 (4-9.5)7 (5.8-10)0.0476 (4.8-9)8 (6-11)0.001
30-d readmission, n (%)24 (13.4)4 (10.3)20 (14.3)0.5148 (9.1)16 (17.6)0.096
Grade I ACn = 334n = 56n = 278n = 154n = 180
30-d mortality, n (%)1 (0.3)01 (0.36)101 (0.56)1
ICU admission, n (%)6 (1.8)1 (1.8)5 (1.8)13 (1.9)3 (1.7)1
LOHS in d16 (5-9)6 (4-8.3)7 (5-9.8)0.0056 (4-7)7 (6-11)< 0.001
30-d readmission, n (%)40 (12)8 (14.3)32 (11.5)0.5622 (14.3)180.229